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The effect of oxidation, oxygenation, and de-oxygenation arising from He gas jet and He plasma
jet treatments on the viability of skin cells cultured in vitro has been investigated. He gas jet treat-
ment de-oxygenated cell culture medium in a process referred to as “sparging.” He plasma jet treat-
ments oxidized, as well as oxygenated or de-oxygenated cell culture medium depending on the
dissolved oxygen concentration at the time of treatment. He gas and plasma jets were shown to
have beneficial or deleterious effects on skin cells depending on the concentration of dissolved oxy-
gen and other oxidative molecules at the time of treatment. Different combinations of treatments
with He gas and plasma jets can be used to modulate the concentrations of dissolved oxygen and
other oxidative molecules to influence cell viability. This study highlights the importance of a pri-
ori knowledge of the concentration of dissolved oxygen at the time of plasma jet treatment, given
the potential for significant impact on the biological or medical outcome. Monitoring and control-
ling the dynamic changes in dissolved oxygen is essential in order to develop effective strategies
for the use of cold atmospheric plasma jets in biology and medicine. Published by AIP Publishing.
[http://dx.doi.org/10.1063/1.4967880]
There is significant optimism that cold atmospheric plas-
mas might one day be effectively and routinely utilized for
targeted cancer therapy,1–3 wound decontamination4–8 and
wound healing.9–11 The action of plasma jets, usually oper-
ated with helium (He) and argon (Ar), is linked to reactive
oxygen and nitrogen species (RONS).12–14 RONS are gener-
ated upon interaction of the plasma jet with ambient air. The
gas flow directs the delivery of RONS to the target tissue
fluid or tissue.15,16 RONS were initially thought to be the
underlying cause of free radical ageing.17 However, it is now
recognized that controlled doses of exogenous RONS could
potentially be beneficial for disease treatment.18,19 Numerous
studies have shown a possible link between plasma-generated
RONS in cell culture media to apoptosis, cell proliferation,
migration, and angiogenesis.20–24
A UV-Visible absorption spectroscopy (UVAS) proce-
dure was developed to monitor the real-time changes in
concentrations of RONS and aqueous oxygen [O2(aq)] in
deionized (DI) water during plasma jet treatment.25 This and
follow-up studies have shown that although He and Ar plasma
jets efficiently deliver RONS into DI water, at the same time
these plasma jets also de-oxygenate DI water.26–28 Given that
plasma jets deliver RONS, it would have been reasonable to
think that water is also oxygenated by plasma jets. But, the
de-oxygenation of water by inert gas plasma jets is perhaps
not so surprising in the context that inert gases have been uti-
lized to de-oxygenate liquids for many decades in a process
referred to as “sparging.”29 And it is important to consider
that an almost negligible percentage of the inert gas, estimated
104%–107%,30 is ionized in cold atmospheric plasma jets.
He is more effective at sparging than other inert gases includ-
ing Ar, as previously discussed by Rollie et al.,31 and more
recently observed for He and Ar plasma jets.26–28 So what is
perhaps surprising is that the effect of sparging of tissue fluids
with inert gas plasma jets has not been commented upon
before. This phenomenon is important in the context that
sparging is likely to produce undesirable hypoxia. Hypoxia
impairs healthy cell and tissue function and inhibits tissue
regeneration,32,33 and is likely to reduce the sensitivity of can-
cer cells to ionizing radiation therapy.34,35 Sparging might
also change pH, with the removal of CO2 out of the fluid.
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Consequently, as a starting point, the influence of sparg-
ing on viability of cells treated with He gas and plasma jets
was examined in this study. HaCaT and HFF-1 cells were
used for keratinocytes and fibroblasts, respectively, which
are the major cells of skin. Skin cells were chosen because of
the intense interest in the plasma stimulation of skin cells to
aid in the healing of chronic wounds.23,37–41 Cells were cul-
tured in Dulbecco modified Eagle’s medium (DMEM) sup-
plemented with 10% (v/v) fetal bovine serum, 100 IU ml1
penicillin, and 100 lg ml1 streptomycin at 37 C under a
humidified atmosphere of 5% CO2. A total of 5000 cells sus-
pended in 200 ll of cell culture medium was added to 96-
well tissue culture polystyrene plates and incubated for 24 h
prior to treatments. The depth of the cell culture medium in
the 96-well was 6 mm. A resazurin-based assay was per-
formed to assess changes in cell viability at 24 h following
the He gas and plasma jet cell treatments. A full description
of the He plasma jet has been provided in previous stud-
ies.26,28 The 4 mm inner diameter He gas and plasma jet tube
was tapered to 650 lm at the nozzle. The distance between
the nozzle and top of the 96-well plate was 2 mm. The He
plasma jet is a capillary dielectric discharge operated with an
applied voltage of 10 kV (peak-to-peak) at 30 kHz and He
flow rate of 0.5 or 0.05 standard litres per minute (slpm),
with ca. He ionization of 107%. The flow rate of the He
gas jet was fixed at 0.5 slpm. We note that both He gas and
plasma jets were operated in open air environments, so there
is a possibility that O2 from air is entrained in the flowing He
as it interacts with water. UVAS of DI water was used to
monitor dynamic changes in the concentrations of H2O2,
NO2
 and NO3
, the main longer-lived RONS generated by
cold atmospheric plasmas,42–46 and O2(aq). Water is the
main constituent (>98%) of DMEM. Liquid volumes used in
cell treatments were 200 ll, but in order to use UVAS, it was
necessary to increase the volume of DI water by 20 to
4 ml. As a consequence, the He gas and plasma jet treatment
times of DI water were extended to minutes in order to illus-
trate the effects on RONS delivery and oxygenation/de-oxy-
genation. This was considered acceptable because, in the
context of this study, the emphasis is on general trends rather
than absolute values.
Figs. 1 and 2 show changes in HaCaT cell and HFF-1
cell viability, respectively, following He gas and plasma jet
treatments. Positive and negative values in Figs. 1 and 2 refer
to an increase and decrease in cell viability, respectively;
both are relative to untreated cells.47 In Fig. 1(a), it can be
seen that HaCaT cell viability decreased as a function of the
He gas jet treatment time. After 300 s of He gas jet treat-
ment, cell viability was reduced by 11.5%. HFF-1s were
less sensitive and a short He gas jet treatment of 60 s pro-
duced a modest increase in cell viability, whereas longer
treatments of 180 and 300 s resulted in a modest decrease in
cell viability (Fig. 2(a)).
The cell viability data was compared to dynamic
changes in RONS and O2(aq) in DI water treated with He
gas and plasma jets (Fig. 3). From Fig. 3(a), a significant
effect of the He gas jet can be seen by a reduction in O2(aq)
of >4 mgl1 in DI water after 5 min of treatment. The
decrease in cell viability, as seen in Fig. 1(a) and to a lesser
degree in Fig. 2(a), is attributed to sparging by the He gas
flow. It is unlikely that the inert He gas could by any other
means physically or chemically interact with the cell culture
medium. The sparging results show that the He gas jet nega-
tively impacts on the viability of HaCaTs more than HFF-1s,
presumably due to the greater sensitivity of keratinocytes to
oxygen tension.48 However, the decrease in cell viability
FIG. 1. The effect of He gas and plasma jet treatments on HaCaT cell viabil-
ity. Cell viability was measured after treatment with the: (a) 0.5 slpm He gas
jet and 0.5 or 0.05 slpm He plasma jet; (b) 300 s of 0.5 slpm He jet followed
immediately after with the 0.5 or 0.05 slpm He plasma jet; (c) 0.5 or 0.05
slpm He plasma jet followed immediately after with the 0.5 slpm He gas jet
for 300 s. He gas and plasma jet treatment times were varied in (a) and the
He plasma jet treatment time was varied in (b) and (c).
FIG. 2. The effect of He gas jet and He plasma jet treatments on HFF-1 cell
viability. Cell viability was measured after treatment with the: (a) 0.5 slpm
He gas jet and 0.5 or 0.05 slpm He plasma jet; (b) 300 s of 0.5 slpm He jet
followed immediately after with the 0.5 or 0.05 slpm He plasma jet; (c) 0.5
or 0.05 slpm He plasma jet followed immediately after with the 0.5 slpm He
gas jet for 300 s. He gas and plasma jet treatment times were varied in (a)
and the He plasma jet treatment time was varied in (b) and (c).
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from sparging was temporary; cell viability fully recovered
at 72 h post He gas jet treatment (data not shown). Therefore,
the decrease in cell viability from sparging may be due to
low O2(aq), temporarily decreasing cellular metabolism.
Cellular metabolic activity can recover after O2 from the
ambient air solvates back into solution after the He gas flow
is extinguished, as seen in Fig. 3(a). In contrast to chronic
hypoxia, we note an acute hypoxia could benefit wound heal-
ing by accelerating keratinocyte migration in response to
oxygen gradients in the wound.48,49
As shown in Fig. 3(b), concomitant to sparging, He
plasma jets also deliver oxidizing species. The combinations
of these two effects, as shown below, are interesting and
potentially exploitable. A series of experiments were con-
ducted to explore different orders of He gas and plasma jet
cell treatments.
The effect of He plasma jet treatment on cell viability is
discussed first. He plasma jet treatment was performed at
two different He flow rates of 0.5 and 0.05 slpm. Fig. 1(a)
shows that at 0.5 slpm, He plasma jet treatment decreased
HaCaT cell viability; however, employing the lower flow
rate of 0.05 slpm did not impact negatively on cell viability,
even at the longer treatment time. A larger decrease in HFF-
1 cell viability was observed after 0.5 slpm He plasma jet
treatment (Fig. 2(a)). There was an almost 100% reduction
in cell viability at t¼ 30 s, and this cannot be attributed to a
sparging effect, as it was not seen in the He gas jet treatment
alone. Consequently, it is evident that HFF-1 cells are more
sensitive to the oxidizing species delivered by the 0.5 slpm
He plasma jet. This effect was still seen for the He plasma
jet treatment at the lower He flow rate of 0.05 slpm, but was
much less marked, ca. 15% at t¼ 30 s from Fig. 2(a). These
results support the previously reported observation that fibro-
blasts are more sensitive to oxidative stress compared to ker-
atinocytes.50 In Fig. 3(b), the DI water was treated with the
He plasma jet for 15 min before extinguishing the plasma
and He gas flow, and monitoring for a further 45 min. As
shown in Fig. 3(b), the He plasma jet generated a higher con-
centration of H2O2 compared to NO2
 and NO3
, which is
important because fibroblasts are particularly sensitive to
exogenous H2O2.
51 During the He plasma jet treatment, the
RONS concentration immediately increased in the DI water,
but at the same time, the DI water was de-oxygenated. The
RONS monitored in this study, H2O2, NO2
 and NO3
, are
all known to create oxidative stress, which can have stimula-
tory or inhibitory effects on cells depending on their dos-
age.51–53 Therefore, He plasma jets can potentially increase
or decrease cell viability through the extent of oxidative stress
versus de-oxygenation. The result depends upon the relative
contributions of each effect, determined by the treatment
parameters such as He gas flow rate and treatment time.
Next examined was how 0.5 slpm He gas jet treatment,
followed immediately by He plasma jet treatment, might
affect cell viability. Having established the He gas jet alone
decreases HaCaT cell viability, it was now seen that cell via-
bility was unaffected by 300 s of He gas jet treatment, if fol-
lowed immediately for 15 s with the 0.5 slpm He plasma jet
(Fig. 1(b)). This is suggestive of a “rescuing” effect from the
He plasma jet. But, following the He gas jet treatment with a
longer 0.5 slpm He plasma jet treatment of 30 s, decreased
cell viability (Fig. 1(b)). With 0.05 slpm He plasma jet treat-
ment for t¼ 15 s, whilst cell viability remained below
untreated cells, cell viability was still higher for these cells
compared to cells treated with the He gas jet alone (in Fig.
1(a)); and moreover, cell viability increased after the 0.05
slpm He gas jet treatment was extended to 30 s (Fig. 1(b)).
In contrast, with HFF-1s, the He gas jet preceding He plasma
jet treatment at 0.5 slpm had no positive effect on cell viabil-
ity, i.e., HFF-1 cell viability remained highly susceptible to
the plasma jet (Fig. 2(b)). At t¼ 30 s of He plasma jet treat-
ment, cell viability was reduced by almost 100%. A small
rescuing effect (from the He gas jet pre-treatment) was seen
with the He plasma jet operated at 0.05 slpm. Fig. 3(c) shows
the UVAS data of DI water first treated for 15 min with the
He gas jet, followed with 15 min of He plasma jet treatment.
In this scenario, when the DI water was first de-oxygenated
by the He gas jet, the He plasma jet now oxygenates the DI
water. Therefore, He plasma jet treatment might help improve
cell viability under hypoxic conditions by oxygenating the
FIG. 3. Dynamic changes in the concentration of H2O2, NO2
, NO3
 and
O2(aq) in DI water during and post He gas and plasma jet treatments. DI
water was treated with the: (a) 0.5 slpm He gas jet for 15 min; (b) 0.5 slpm
He plasma jet for 15 min; (c) 0.5 slpm He gas jet for 5 min followed with the
0.5 slpm He plasma jet for 15 min; and (d) 0.5 slpm He plasma jet for
15 min followed with the 0.5 slpm He gas jet for 15 min.
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solution, provided the flux of RONS is kept low enough to
not induce excessive oxidative stress.
In the next experiments, the treatment order was
reversed: i.e., cells were first treated with the He plasma jets
followed by the He gas jet. Surprisingly, in this order HaCaT
cell viability had increased when the 0.5 slpm He plasma jet
was first applied for 15 s to cells (Fig. 1(c)). Even at the lon-
ger treatment time of 30 s, whilst cell viability was reduced,
it was still higher on average than untreated cells (Fig. 1(c)).
This result indicates that applying the He gas jet directly
after He plasma jet treatment at the higher flow rate (0.5
slpm), somehow (more than) “rescued” cells compared to
0.5 slpm He plasma jet treatment alone. This order produced
an overall increase in cell viability. When the He plasma jet
was operated at the lower flow rate of 0.05 slpm, changing
the order of treatment had only a minor effect compared to
treatment with only the 0.05 slpm He plasma jet. In contrast,
with HFF-1s no rescuing effect was observed by following
the higher flow rate He plasma jet treatment with the He gas
jet. A larger decrease in cell viability was observed for treat-
ment with the 0.5 slpm He plasma jet followed with He gas
jet treatment (Fig. 2(c)). This effect is almost identical to
that seen for HFF-1s treated with the 0.5 slpm He plasma jet
(in Fig. 2(a)). At this flow rate, HFF-1s are vulnerable to the
oxidative species delivered by the He plasma jet. However,
HFF-1s do marginally better when subjected to treatment
with the lower flow rate (0.05 slpm) He plasma jet followed
by the He gas jet, compared to treatment with the 0.05 slpm
He plasma jet alone (Fig. 2(c)). In Fig. 3(d), when the DI
water was treated with the He plasma jet for 15 min followed
with 15 min of He gas jet treatment, the He gas flow does not
affect the RONS concentrations in solution, but it keeps the
O2(aq) concentration lower than in the scenario where no He
gas jet treatment was applied (in Fig. 3(b)). O2(aq) is also a
reactive free radical, in that it has two unpaired electrons,
and it can itself participate in intracellular RONS genera-
tion.18,54,55 Therefore, keeping the O2(aq) concentration low,
when cells are experiencing excessive oxidative stress, possi-
bly helps maintain cell viability.
H2O2 and O2(aq) levels were measured directly in the
cell culture medium immediately after He gas and plasma jet
treatments (Table I). These measurements were taken using
a “Free Radical Analyzer” (WPI Instruments), as recom-
mended by Taniguchi and Gutteridge.56 The percentage
(tension) of O2(aq) was 21% for cell medium that was
allowed to equilibrate with ambient air; 0% when purged with
N2 and 100% when purged with O2. O2(aq) remained
unchanged for up to 30 s of 0.05 slpm He gas jet treatment.
But the O2(aq) decreased to 17.5% and 15.3% after 0.5 slpm
He gas treatment for 15 and 30 s, respectively. Approximately
75% of O2(aq) was purged from the cell medium after 300 s
of 0.5 slpm He gas jet treatment. Similarly, after 15 and 30 s
He plasma jet treatments, the O2(aq) tension did not change at
0.05 slpm, but decreased at 0.5 slpm; however, not to the
same degree as seen with the He gas jet alone; attributed to
the plasma jet also delivering oxidative species into the cell
medium. As expected, the 0.05 slpm He plasma jet treatments
of 15 and 30 s produced lower concentrations of H2O2 (2.8
and 5.5lM) than at the higher flow rate (0.5 slpm) He plasma
jet treatments (17.6 and 73.8lM for t¼ 15 and 30 s, respec-
tively). Concentrations of H2O2 above 10lM can be cyto-
toxic,18 as observed in this study. The pH of the cell medium
remained constant at 8.56 0.06 for all treatments.
These results show that sparging can significantly impact
on in vitro cell culture experiments where inert gas plasma
jets are used to treat cells in small culture wells with small
volumes of less than 1 ml. In extrapolating this effect to the
treatment of real tissue, it should be considered that the situa-
tion is no longer static and that the blood flow might to some
extent mitigate de-oxygenation. Also, recent reports on the
effects of plasma-skin treatment have shown that plasma treat-
ment increases sub-cutaneous blood flow and blood O2(aq)
content;57–59 so it should be considered that plasma might also
increase local tissue O2(aq) content. It is also worth noting
that plasma-induced oxygenation/de-oxygenation in open
wounds could be very different to covered wounds.26,60
In conclusion, although the role and effects of RONS
such as H2O2, NO2
 and NO3
, have attracted a significant
amount of attention in plasma medicine studies, particularly
in explaining in vitro culture studies, potential changes in the
concentration of O2(aq) have largely been overlooked. But
the O2(aq) concentration will affect the biological outcome
of the plasma treatment of cells in culture. Monitoring the
O2(aq) concentration is relatively straightforward and could
help in the interpretation of in vitro studies and therefore in
the development of more effective strategies in the applica-
tion of cold atmospheric plasma in biology and medicine.
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